Management of Acute Sleeping‑Pill Overdose

Initial Stabilization and Airway Management

Establish an open airway immediately; provide bag‑mask ventilation if respiratory depression occurs, maintain oxygen saturation ≥ 95 % on room air, and proceed to endotracheal intubation when the patient cannot protect the airway. 1
Contact the regional poison‑control center as soon as the patient presents. 1

The American Heart Association assigns a Class III (Harm) recommendation to routine use of flumazenil in benzodiazepine or Z‑drug overdoses; it should not be used routinely because of the high risk of precipitating seizures and withdrawal. 1
Flumazenil is contraindicated in patients who are benzodiazepine‑dependent, have a history of seizures, or are chronic benzodiazepine users. 1
Flumazenil may be considered only in a known pure benzodiazepine overdose in a procedurally sedated adult without any contraindications; dosing starts at 0.2 mg IV and may be titrated up to a maximum of 1 mg (pediatric dose ≈ 0.01 mg/kg). 1

No specific pharmacologic antidote exists for barbiturate poisoning; treatment relies on optimal supportive care. 2
For life‑threatening poisoning with long‑acting agents (e.g., phenobarbital, primidone), intermittent hemodialysis is the preferred extracorporeal therapy when any of the following criteria are met: life‑threatening toxicity, prolonged coma despite supportive measures, or refractory hemodynamic instability. 2
If hemodialysis is unavailable, hemoperfusion or continuous renal replacement therapy are acceptable alternatives. 2
Extracorporeal toxin removal should be initiated only when the above life‑threatening criteria are present, not solely based on the ingested dose or serum concentration. 2
Peritoneal dialysis and therapeutic plasma exchange are not recommended for barbiturate poisoning because clearance is insufficient. 2

Administer activated charcoal (≈ 1 g/kg orally) only if the patient presents within 1–4 hours of ingestion and has a protected airway. 1

Continuous monitoring for respiratory depression, loss of protective airway reflexes, and declining mental status is mandatory. 1
Observe the patient for a minimum of 24–48 hours because most sleeping‑pill agents have long half‑lives (e.g., clonazepam ≈ 22–32 h). 3
Continuously monitor oxygen saturation and maintain stable vital signs throughout the observation period. [1][3]

Never use flumazenil in undifferentiated overdoses or when benzodiazepine dependence is suspected; the risk of life‑threatening withdrawal seizures outweighs any potential benefit. 1
Do not discharge a patient based solely on early clinical improvement; the full 24–48‑hour observation must be completed to detect delayed resedation. 3
Obtain a formal psychiatric evaluation before discharge in intentional overdose cases; discharge without psychiatric clearance is considered unsafe. [1][3]